Brain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementia

[1]  L. Bertola,et al.  Brain-enriched MicroRNA-184 is downregulated in older adults with major depressive disorder: A translational study. , 2019, Journal of psychiatric research.

[2]  Ana Kozomara,et al.  miRBase: from microRNA sequences to function , 2018, Nucleic Acids Res..

[3]  Chunshui Yu,et al.  Neurobiological substrates underlying the effect of genomic risk for depression on the conversion of amnestic mild cognitive impairment , 2018, Brain : a journal of neurology.

[4]  David A Bennett,et al.  Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.

[5]  H. Feilotter,et al.  Examining redox modulation pathways in the post-mortem frontal cortex in patients with bipolar disorder through data mining of microRNA expression datasets. , 2018, Journal of psychiatric research.

[6]  Michael J. Devine,et al.  Mitochondria at the neuronal presynapse in health and disease , 2018, Nature Reviews Neuroscience.

[7]  Nick C Fox,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[8]  G. Turecki,et al.  Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response , 2018, Current opinion in psychiatry.

[9]  N. Pochet,et al.  Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease , 2017, Molecular Neurodegeneration.

[10]  J. Ioannidis,et al.  Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses , 2017, Alzheimer's & Dementia.

[11]  Charles C. White,et al.  Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data , 2017, PLoS medicine.

[12]  Eckart Meese,et al.  The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster , 2017, Neurobiology of Aging.

[13]  Madhav Thambisetty,et al.  A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease. , 2017, Cell systems.

[14]  T. Hanihara,et al.  Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late‐life depression , 2016, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[15]  A. Teixeira,et al.  Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies. , 2016, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[16]  David A. Bennett,et al.  Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study , 2016, The Lancet Neurology.

[17]  D. Bennett,et al.  Late-life depression is not associated with dementia-related pathology. , 2016, Neuropsychology.

[18]  S. Leurgans,et al.  Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons , 2015, Neurology.

[19]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[20]  Alberto Forte,et al.  Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders. , 2015, Journal of affective disorders.

[21]  S. Leurgans,et al.  Hippocampal sclerosis and TDP‐43 pathology in aging and Alzheimer disease , 2015, Annals of neurology.

[22]  S. Quake,et al.  A survey of human brain transcriptome diversity at the single cell level , 2015, Proceedings of the National Academy of Sciences.

[23]  Alon Chen,et al.  Determining the role of microRNAs in psychiatric disorders , 2015, Nature Reviews Neuroscience.

[24]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[25]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[26]  David A Bennett,et al.  Clinical-pathologic study of depressive symptoms and cognitive decline in old age , 2014, Neurology.

[27]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[28]  E. Deneris,et al.  MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity , 2014, Neuron.

[29]  Peilong Li,et al.  Role of TGFBIp in Wound Healing and Mucin Expression in Corneal Epithelial Cells , 2017, Yonsei medical journal.

[30]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[31]  Yogesh Kumar Dwivedi,et al.  The Involvement of MicroRNAs in Major Depression, Suicidal Behavior, and Related Disorders: A Focus on miR-185 and miR-491-3p , 2013, Cellular and Molecular Neurobiology.

[32]  D. Bennett,et al.  TDP-43 pathology, cognitive decline, and dementia in old age. , 2013, JAMA neurology.

[33]  Aikaterini S. Papadopoulou,et al.  Alteration of the microRNA network during the progression of Alzheimer's disease , 2013, EMBO molecular medicine.

[34]  J. Schneider,et al.  Much of late life cognitive decline is not due to common neurodegenerative pathologies , 2013, Annals of neurology.

[35]  R. Palmer,et al.  Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline , 2013, Alzheimer's & Dementia.

[36]  C. Reynolds,et al.  Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies , 2013, British Journal of Psychiatry.

[37]  M. Iijima,et al.  Mitochondrial dynamics in neurodegeneration. , 2013, Trends in cell biology.

[38]  Yogesh K. Dwivedi,et al.  MicroRNA Expression Is Down-Regulated and Reorganized in Prefrontal Cortex of Depressed Suicide Subjects , 2012, PloS one.

[39]  Peifeng Li,et al.  miR-484 regulates mitochondrial network through targeting Fis1 , 2012, Nature Communications.

[40]  Alan J. Thomas,et al.  Neuropathological correlates of late-life depression in older people , 2011, British Journal of Psychiatry.

[41]  G. McKhann,et al.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model , 2010, Proceedings of the National Academy of Sciences.

[42]  P. Reddy,et al.  Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. , 2010, Journal of Alzheimer's disease : JAD.

[43]  G. Schratt microRNAs at the synapse , 2009, Nature Reviews Neuroscience.

[44]  S. Leurgans,et al.  The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.

[45]  George Perry,et al.  Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease , 2009, The Journal of Neuroscience.

[46]  Michael Brudno,et al.  SHRiMP: Accurate Mapping of Short Color-space Reads , 2009, PLoS Comput. Biol..

[47]  Xiongwei Zhu,et al.  Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins , 2008, Proceedings of the National Academy of Sciences.

[48]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[49]  R. Robinson,et al.  The construct of minor and major depression in Alzheimer's disease. , 2005, The American journal of psychiatry.

[50]  Constantine G Lyketsos,et al.  Depression in Alzheimer’s disease: heterogeneity and related issues , 2003, Biological Psychiatry.

[51]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[52]  L. Berkman,et al.  Two Shorter Forms of the CES-D Depression Symptoms Index , 1993 .

[53]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.